BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25135605)

  • 1. Next-generation sequencing is a credible strategy for blood group genotyping.
    Fichou Y; Audrézet MP; Guéguen P; Le Maréchal C; Férec C
    Br J Haematol; 2014 Nov; 167(4):554-62. PubMed ID: 25135605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Next Generation Sequencing the future of blood group testing?
    Tilley L; Grimsley S
    Transfus Apher Sci; 2014 Apr; 50(2):183-8. PubMed ID: 24667159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 454-Sequencing™ for the KEL, JR, and LAN Blood Groups.
    Wieckhusen C; Bugert P
    Methods Mol Biol; 2015; 1310():123-33. PubMed ID: 26024631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended blood group molecular typing and next-generation sequencing.
    Liu Z; Liu M; Mercado T; Illoh O; Davey R
    Transfus Med Rev; 2014 Oct; 28(4):177-86. PubMed ID: 25280589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the use of SNaPshot for predicting blood group antigens.
    Latini FR; Castilho LM
    Immunohematology; 2015; 31(2):53-7. PubMed ID: 26495889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO genotyping with next-generation sequencing to resolve heterogeneity in donors with serology discrepancies.
    Wu PC; Lin YH; Tsai LF; Chen MH; Chen PL; Pai SC
    Transfusion; 2018 Sep; 58(9):2232-2242. PubMed ID: 29770457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards allele-level human leucocyte antigens genotyping - assessing two next-generation sequencing platforms: Ion Torrent Personal Genome Machine and Illumina MiSeq.
    Duke JL; Lind C; Mackiewicz K; Ferriola D; Papazoglou A; Derbeneva O; Wallace D; Monos DS
    Int J Immunogenet; 2015 Oct; 42(5):346-58. PubMed ID: 26119888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.
    Orzińska A; Guz K; Mikula M; Kulecka M; Kluska A; Balabas A; Pelc-Kłopotowska M; Ostrowski J; Brojer E
    Blood Transfus; 2018 May; 16(3):285-292. PubMed ID: 28287381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of next-generation sequencing for the determination of rare blood group genotypes.
    Jakobsen MA; Dellgren C; Sheppard C; Yazer M; Sprogøe U
    Transfus Med; 2019 Jun; 29(3):162-168. PubMed ID: 29265667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation.
    Moonsamy PV; Williams T; Bonella P; Holcomb CL; Höglund BN; Hillman G; Goodridge D; Turenchalk GS; Blake LA; Daigle DA; Simen BB; Hamilton A; May AP; Erlich HA
    Tissue Antigens; 2013 Mar; 81(3):141-9. PubMed ID: 23398507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass-scale donor red cell genotyping using real-time array technology.
    Denomme GA; Schanen MJ
    Immunohematology; 2015; 31(2):69-74. PubMed ID: 26495892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging strategies of blood group genotyping for patients with hemoglobinopathies.
    Belsito A; Magnussen K; Napoli C
    Transfus Apher Sci; 2017 Apr; 56(2):206-213. PubMed ID: 28040400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-laboratory evaluation of SNP-based forensic identification by massively parallel sequencing using the Ion PGM™.
    Eduardoff M; Santos C; de la Puente M; Gross TE; Fondevila M; Strobl C; Sobrino B; Ballard D; Schneider PM; Carracedo Á; Lareu MV; Parson W; Phillips C
    Forensic Sci Int Genet; 2015 Jul; 17():110-121. PubMed ID: 25955683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular approaches to transfusion medicine in Polynesians and Maori in New Zealand.
    Edinur HA; Dunn PP; Lea RA; Chambers GK
    Int J Immunogenet; 2013 Dec; 40(6):460-70. PubMed ID: 23870060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massively parallel and multiplex blood group genotyping using next-generation-sequencing.
    Boccoz SA; Fouret J; Roche M; Lachuer J; Legras-Lachuer C; Corgier BP; Marquette CA
    Clin Biochem; 2018 Sep; 60():71-76. PubMed ID: 30092181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies.
    Millat G; Chanavat V; Rousson R
    Clin Chim Acta; 2014 Jun; 433():266-71. PubMed ID: 24721642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex ligation-dependent probe amplification (MLPA) assay for blood group genotyping, copy number quantification, and analysis of RH variants.
    Veldhuisen B; van der Schoot CE; de Haas M
    Immunohematology; 2015; 31(2):58-61. PubMed ID: 26495890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology methods in immunohematology].
    Tournamille C
    Transfus Clin Biol; 2013 May; 20(2):72-9. PubMed ID: 23587623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: A comparison.
    Profaizer T; Lázár-Molnár E; Pole A; Delgado JC; Kumánovics A
    Int J Immunogenet; 2017 Aug; 44(4):164-168. PubMed ID: 28556460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.